Complete remission following treatment with bortezomib, doxorubicin, dexamethasone and autologous stem cell transplant in patient with immunoglobulin E multiple myeloma

Leukemia and Lymphoma

Volumn 51, Issue 12, 2010, Pages 2291-2294

  Pogłód, Ryszard ^a   Kraj, Maria ^a   Kruk, Barbara ^a   Hagedorna Tronina, Renata ^a   Łetowska, Magdalena ^a   Warzocha, Krzysztof ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BENCE JONES PROTEIN; BETA 2 MICROGLOBULIN; BORTEZOMIB; CALCIUM; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; M PROTEIN; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE PAIN; CALCIUM BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CELL INFILTRATION; CELL SUBPOPULATION; CHROMOSOME 13; CHROMOSOME 6; CHROMOSOME DELETION; CHROMOSOME Q BAND; CREATININE BLOOD LEVEL; CYTOGENETICS; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HEMOGLOBIN BLOOD LEVEL; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; KARYOTYPE 46,XY; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; MYELOMA; MYELOMA CELL; OSTEOLYSIS; PATIENT REFERRAL; PLASMA CELL; PLASMA CELL DYSCRASIA; PLASMA CELL LEUKEMIA; PLASMACYTOMA; PLASMACYTOSIS; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; SKIN ALLERGY; SKIN DEFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; COMBINED MODALITY THERAPY; DEXAMETHASONE; DOXORUBICIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PYRAZINES; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 78650060551     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.523128     Document Type: Article

References (14)

1. Johansson SG, Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology 1967;13: 383-394.
2. Wozney JL, Ahmed F, Bayerl MG, Ehmann WC, Talamo G. Skin involvement in immunoglobulin E multiple myeloma. J Clin Oncol 2009;27:637-638.
3. Takemura Y, Ikeda M, Kobayashi K, et al. Plasma cell leukemia producing monoclonal immunoglobulin E. Int J Hematol 2009;90:402-406.
4. Ogawa M, Kochwa S, Smith C, Ishizaka K, McIntyre OR. Clinical aspects of IgE myeloma. N Engl J Med 1969;281: 1217-1220.
5. Dammacco F, Miglietta A, Tribalto M, Mandelli F, Bonomo L. The expanding spectrum of clinical and laboratory features of IgE myeloma. (Report of a case and review of the literature). Ric Clin Lab 1980;10:583-590.
6. Endo T, Okumura H, Kikuchi K, et al. Immunoglobulin E (IgE) multiple myeloma: a case report and review of the literature. Am J Med 1981;70:1127-1132.
7. Kairemo KJA, Lindber M, Prytz M. IgE myeloma: a case presentation and review of the literature. Scand J Clin Lab Invest 1999;59:451-455.
8. Alexander RL Jr, Roodman ST, Petruska PJ, Tsai CC, Janney CG. A new case of IgE myeloma. Clin Chem 1992;38:2328-2332.
9. Yamagata N, Shismazaki C, Goto H, et al. IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon. Am J Hematol 1994;45: 262-264.
10. Macro M, André I, Comby E, et al. IgE multiple myeloma. Leuk Lymphoma 1999;32:597-603.
11. Wang M, Qiang H, Yang T. IgE myeloma with elevated level of serum CA125. Zhejiang Univ Sci B 2009;10:559-562.
12. Garand R, Avet-Loiseau H, Accard F, Moreau P, Harousseau JL, Bataille R. t (11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma. Leukemia 2003;17:2032-2035.
13. Ludwig H, Vormittag W. Benign monoclonal IgE gammopathy. Br Med J 1980;281:539-540.
14. Hayes MJ, Carey JL, Krauss JC, Hedstrom DL, Gulbranson RL, Keren DF. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma. Eur J Haematol 2007;78:353-357.